Sage Journals: Discover world-class research

Abstract

This article has been retracted, and the online PDF replaced with this retraction notice.

Keywords

Sclareol cell apoptosis mitochondrial membrane potential osteosarcoma cells

1. Introduction

Osteosarcoma is a primary malignant bone tumor commonly observed in children or teenagers, and occupies about 5% of total childhood tumors [1]. Osteosarcoma is commonly occurred in epiphysis end of long bones such as femora and humeral, and has characteristics such as high malignancy and invasiveness [2]. With abundant blood flow at epiphysis, osteosarcoma cell is predisposed to have distal metastasis via blood circulation, leading to treatment difficulty and unfavorable prognosis, bringing heavy burdens for public health [3]. Recent study has revealed certain anti-tumor effect of sclareol in inhibiting tumor growth such as osteosarcoma, breast cancer, gastric cancer and colorectal carcinoma [4, 5]. Sclareol, also named as sclarcol, is a di-tert-alcohol firstly extracted from sage clary plants in 1982 and later in other plants [6]. Study has found its LD ${}_{50}$ was larger than 5000 mg/kg in mice and rabbits, making it a low toxicity compound [7]. Meanwhile, active compound using sclareol as material has multiple functions including anti-bacteria, anti-spasmodic and anti-viral, making it an important drug material for synthesizing various drugs and pesticides [8]. Sclareol has high anti-bacterial activity against Staphylococcus aureus, Staphylococcus epidermidis and E. coli [4]. It also had certain anti-inflammation effects besides anti-bacterial functions [5]. Using sclareol as the basal material, 13-sclareol hydrochloride compound has been synthesized with certain anti-spasmodic functions [6]. Sclareol and its derivatives have cytotoxicity on multiple tumor cells and can inhibit tumor growth [7]. Although having anti-tumor effects, the functional mechanism of sclareol is still unknown. This study thus treated osteosarcoma cells with sclareol solution, to observe the effect of various doses of drugs on the growth and proliferation of osteosarcoma cells, in an attempt to investigate the functional mechanism of sclareol on osteosarcoma growth.

2. Materials and methods

2.1 Reagents and equipment

DMEM medium, fetal bovine serum (FBS) and trypsin were purchased from Gibco (US). DMSO, sclareol and PI dyes were produced by Sigma (US). CCK8 test kit was obtained from Toyobo (Japan). Culture dish was a product of Corning (US). CO ${}_{2}$ cell incubator was produced by Thermo (US). Microplate reader was obtained from Bio-tek (US). Flow cytometry equipment was provided by BD Biosciences (US).

2.2 Cell line and culture

MG63 osteosarcoma cells were purchased from Shanghai Cell Biology Institute, Chinese Academy of Sciences. Cells were kept in DMEM medium containing 10% FBS, and were kept in a humidified chamber with 5% CO ${}_{2}$ at 37 ${}^{\circ}$ C.

2.3 CCK8 assay

Cells at log-phase were collected by centrifugation. After re-suspension, cells were inoculated in 96-well plate (1 $\times$ 10 ${}^{4}$ per well). The plate was incubated in a humidified chamber with 5% CO ${}_{2}$ at 37 ${}^{\circ}$ C for 24 hours. Gradient concentrations of sclareol (0.5 $\mu$ M, 1.0 $\mu$ M, 5.0 $\mu$ M, 10.0 $\mu$ M, 20.0 $\mu$ M, 40.0 $\mu$ M and 80.0 $\mu$ M) and blank control/DMSO were applied to cells (N $=$ 6 each group). At different time points (24 hours, 48 hours and 72 hours), the medium was removed to rinse cells using PBS. 0.1 mL 10% CCK8 working solution was added into each well for further 2-hour incubation. Absorbance value of each well was measured in a microplate reader at 450 nm wavelength. Using concentration of sclareol as the horizontal axis, the growth curve of MG63 cells was plotted using absorbance value as the vertical axis. The LC ${}_{50}$ value of sclareol was deduced on the growth curve.

Figure 1.

Effect of sclareol on MG63 cell proliferation.

2.4 Apoptosis analysis

MG63 cells were treated with DMSO (control) or sclareol. After 48 hours, the medium was removed, following by the digestion by 0.25% trypsin. Cells were rinsed in DMEM to prepare single cell suspensions, which were centrifuged at 1000 g for 5 min. PBS was then added to rinse cells again for further centrifugation. Supernatants were removed with adding 0.2 mL blocking buffer. The mixture was then incubated at room temperature for 15 min. 0.5 mL buffer solution was then added, followed by centrifugation. 0.2 mL annexin V dye was added, mixed and incubated for 10 min. After rinsing and washing by centrifugation, PI dye was added. The mixture was then loaded for flow cytometry to detect apoptosis.

Figure 2.

Sclareol induced MG63 cell apoptosis. A to D, flow cytometry for apoptosis in MG63 cells treated with DMSO (A), 2 $\mu$ M sclareol (B), 4 $\mu$ M sclareol (C) and 8 $\mu$ M sclareol (D). Quantified analysis of apoptotic cells (%) (annexin-V positive $+$ PI positive $+$ annexin-V and PI double positive cells) (E) *, $p<$ 0.05 compared to DMSO. This experiment was performed in triplicate.

2.5 Mitochondrial membrane potential (

\Delta\Psi

) analysis

Cells were digested in 0.25% trypsin, and were rinsed to prepare single cell suspension, which was centrifuged at 1000 g for 5 min. DMEM medium was then added to prepare single cell suspension (1 $\times$ 10 ${}^{6}$ per mL), which was then mixed with 5 $\mu$ g/ml JC-1. Cells were incubated in a humidified chamber with 5% CO ${}_{2}$ at 37 ${}^{\circ}$ C for 1 hour. After washed by PBS buffer, cells were resuspended in PBS and analyzed by flow cytometry.

Figure 3.

Western blot analysis of the expression of cytochrome c, Bax and Bcl-2 in cells after treatment with different concentrations of sclareol.

Meanwhile, cells were mixed with 10 $\mu$ L Rhodamine 123 dye and incubated in a humidified chamber with 5% CO ${}_{2}$ at 37 ${}^{\circ}$ C for 1 hour. 0.1 mL cell suspensions were added on glass slide to observe fluorescence intensity (FI) under a laser confocal microscope at 488 nm/590 nm wavelength for the quantification of $\Delta\Psi$ .

2.6 Western blot

RIPA lysis buffer was added into cells for extraction of total proteins, which was quantified by BCA assay. 40 $\mu$ g proteins were then separated by SDS-PAGE and transferred into a PVDF membrane. After blocked with 5% skimmed milk at room temperature for 2 h and washing by PBST three times, the membrane was incubated with primary antibody (1:1000) overnight at 4 ${}^{\circ}$ C then incubated with secondary antibody (1:10000) for 1 h at room temperature. At last, the membrane was developed using ECL reagent and positive band was visualized.

2.7 Statistical analysis

SPSS 20.0 software was used to process all collected data. Measurement data were presented as mean $\pm$ standard deviation (SD) and were compared by analysis of variance (ANOVA). Enumeration data were presented as percentiles and were analyzed by chi-square method. A statistical analysis was defined when $p<$ 0.05.

Figure 4.

Sclerol’s effect on mitochondrial membrane potential. Flow cytometry was performed for measuring mitochondrial membrane potential in MG63 cells treated with DMSO (A), 2 $\mu$ M sclareol (B), 4 $\mu$ M sclareol (C) and 8 $\mu$ M sclareol (D). Quantified data was also provided (E).

Figure 5.

Sclerol’s effect on mitochondrial membrane potential. Confocal microscopy analysis was performed for measuring mitochondrial membrane potential in MG63 cells treated with DMSO, 2 $\mu$ M sclareol, 4 $\mu$ M sclareol and 8 $\mu$ M sclareol.

3. Results

3.1 Effect of sclareol on MG63 cell proliferation

MG63 osteosarcoma cells were divided into control, DMSO and experimental group, which received no treatment, DMSO treatment and gradient concentration of sclareol (0.5 $\mu$ M, 1.0 $\mu$ M, 5.0 $\mu$ M, 10.0 $\mu$ M, 20.0 $\mu$ M, 40.0 $\mu$ M and 80.0 $\mu$ M). After 24 hours, 48 hours or 72 hours, CCK8 assay was performed to determine the effect of drug on MG63 cell proliferation. As shown in Fig. 1, low dose sclareol ( $\leqslant$ 5.0 $\mu$ M) had relatively less significant effects on cell proliferation, while high dose drug ( $>$ 5.0 $\mu$ M) significantly inhibited MG63 cell proliferation. Under the same concentration of drug, the proliferation ability of cells was reduced with prolonged treatment time (F $=$ 17.82, $p<$ 0.05). LC ${}_{50}$ values of sclareol on MG63 cells were 18.8 $\mu$ M, 11.0 $\mu$ M and 6.3 $\mu$ M at 24 hours, 48 hours and 72 hours, respectively. These results suggested sclareol could inhibit MG63 cell proliferation.

3.2 Sclareol induced MG63 cell apoptosis

To study the mechanism of sclareol on inhibiting MG63 cell proliferation, we further investigated the effect of sclareol on MG63 cell apoptosis. We divided cells into DMSO group and treatment group, which was further sub-divided into 2.0 $\mu$ M, 4.0 $\mu$ M and 8.0 $\mu$ M. Forty-eight hours after treatment, flow cytometry was used to measure cell apoptosis. As shown in Fig. 2, sclareol induced MG63 cell apoptosis, with apoptotic cell ratio at 13.8%, 24.1% and 37.3% for 2.0 $\mu$ M, 4.0 $\mu$ M and 8.0 $\mu$ M of sclareol, respectively. DMSO-treated cells, however, had apoptotic cell ratio at 5.1%. Significant difference existed between control and experimental group (F $=$ 22.65, $p<$ 0.05). Consistently, increased expression of cytochrome c and Bax was observed in cells after treatment with sclareol in a dose-dependent manner (Fig. 3). However, the expression of anti-apoptotic molecule Bcl-2 was decreased after sclareol treatment (Fig. 3).

3.3 Effect of sclareol on mitochondrial membrane potential ( $\Delta\Psi$ )

To evaluate the effect of sclareol on mitochondrial membrane potential, flow cytometry was performed using JC-1 reagent. Twelve hours after treatment with different concentrations of sclareol (2.0 $\mu$ M, 4.0 $\mu$ M and 8.0 $\mu$ M), JC-1 was added into the cells for flow cytometric analysis of mitochondrial membrane potential. As shown in Fig. 4A–E, MG63 cells had significantly depressed $\Delta\Psi$ in sclareol-treated cells in a dose-dependent manner, consistent with fluorescence analysis of mitochondrial membrane potential (Fig. 5), indicating that sclareol could decrease mitochondrial membrane potential of MG63 cells.

4. Discussion

Sclareol is a di-tert-alcohol firstly extracted from sage clary plants, which are mainly distributed in China and Mediterranean regions [8]. Traditionally it is used to produce perfumes and additives, and also as materials for drug development [9]. Previous reports indicated the anti-tumor activity of sclareol as it showed inhibitory effects on osteosarcoma, breast cancer, gastric carcinoma and colorectal carcinoma, but leaving the exact mechanisms largely unknown [15]. To study the anti-tumor activity of sclareol, we selected MG63 osteosarcoma cell as the model, in which the effect of sclareol on cell viability was observed using CCK8 assay. All cells were divided into blank control, solvent control and experimental group. Our results showed decreased proliferation ability of cells after sclareol treatment. Within certain dose range, there was a negative correlation between sclareol concentration and cell viability. Under the same concentration of drug, the proliferation ability of MG63 cell was decreased with elongated treatment period. To further study the mechanism underlying sclareol inhibition on osteosarcoma cells, we divided cells into DMSO and sclareol group, in which flow cytometry was used to test cell apoptosis. Our results showed significantly elevated apoptotic cell ratio in treatment group comparing to DMSO treated cells ( $p<$ 0.05). Meanwhile, the expression of cytochrome c and Bax was increased and Bcl-2 expression was reduced after sclareol treatment. With higher concentration of sclareol, the apoptotic percentage of MG63 cells was gradually increased, supporting the induction of osteosarcoma cell apoptosis by sclareol.

However, the mechanism underlying apoptosis of MG63 cells induced by sclareol is still unknown. Previous literature showed certain role of mitochondria in cell apoptosis, whose membrane potential has close relationship with cell apoptosis [16]. As an organelle with double lipid membrane, mitochondrion is the main location for producing energy of cell aerobic respiration. It also participates in signal transduction and cell apoptosis, with regulatory role on cell growth and cell cycle [17]. Recent study has shown the decrease of mitochondrial membrane potential may change permeability of membrane and induce further apoptosis [18]. Therefore cell apoptosis can be observed by measuring the membrane potential of mitochondria. To further illustrate the molecular mechanism underlying sclareol-induced apoptosis, we divided MG63 cells into both DMSO and sclareol treated group, in which the effect of sclareol on membrane potential of cells was assessed by flow cytometry using JC-1 reagent. Results showed significantly depressed mitochondrial membrane potential of sclareol-treated MG63 cells compared to DMSO-treated ones ( $p<$ 0.05). Higher dosage of sclareol had more significantly depressed membrane potential, suggesting the role of sclareol in decreasing mitochondrial membrane potential in osteosarcoma cells.

In summary, sclareol can decrease mitochondrial membrane potential of MG63 osteosarcoma cells and alter mitochondrial biological functions, thus inducing cell apoptosis and inhibiting osteosarcoma cell growth and proliferation.

Footnotes

Conflict of interest

None.

References

Jemal

et al., Global cancer statistics, CA Cancer J Clin 61(2) (2011), 69–90.

Osborne

T.S.

and Khanna

, A review of the association between osteosarcoma metastasis and protein translation, J Comp Pathol 146(2-3) (2012), 132–142.

Yang

and Zhang

, New molecular insights into osteosarcoma targeted therapy, Curr Opin Oncol 25(4) (2013), 398–406.

Zhong

et al., Sclareol exerts anti-osteoarthritic activities in interleukin-1beta-induced rabbit chondrocytes and a rabbit osteoarthritis model, Int J Clin Exp Pathol 8(3) (2015), 2365–2374.

Shakeel

U.R.

et al., Design and Synthesis of Antitumor Heck-Coupled Sclareol Analogues: Modulation of BH3 Family Members by SS-12 in Autophagy and Apoptotic Cell Death, J Med Chem 58(8) (2015), 3432–3444.

Huang

G.J.

Pan

C.H.

and Wu

C.H.

, Sclareol exhibits anti-inflammatory activity in both lipopolysaccharide-stimulated macrophages and the lambda-carrageenan-induced paw edema model, J Nat Prod 75(1) (2012), 54–59.

Noori

et al., Sclareol modulates the Treg intra-tumoral infiltrated cell and inhibits tumor growth in vivo , Cell Immunol 263(2) (2010), 148–153.

Noori

Hassan

Z.M.

and Salehian

, Sclareol reduces CD4+ CD25+ FoxP3+ Treg cells in a breast cancer model in vivo , Iran J Immunol 10(1) (2013), 10–21.

Ulubelen

Miski

and Johansson

, Terpenoids from Salvia palaestina, Phytochemistry 24(6) (1985), 1386–1387.

10.

Little

B.J.

Gerke

T.L.

and Lee

J.S.

, Mini-review: the morphology, mineralogy and microbiology of accumulated iron corrosion products, Biofouling 30(8) (2014), 941–948.

11.

Juan

M.C.

Sofia

and Joaquin

, 8a, 13-Epoxy-14, 15-dinorlabd-12-ene (Sclareol Oxide)[(+)-(4aR6As, 10As, 10bR)-3, 4a, 7, 7, 10a-Pentamethyl-4a, 5, 6, 6a, 7, 8, 9, 10, 10a, 10b-decahydro-1H-benz-o[f]chromene], Molbank 2003(4) (2003), 304.

12.

Demetzos

and Pippa

, Advanced drug delivery nanosystems (aDDnSs): A mini-review, Drug Deliv 21(4) (2014), 250–257.

13.

et al., Synthesis and antifungal activity of ethers, alcohols, and iodohydrin derivatives of sclareol against phytopathogenic fungi in vitro , Bioorg Med Chem Lett 25(14) (2015), 2773–2777.

14.

Fujimoto

et al., Sclareol induces plant resistance to root-knot nematode partially through ethylene-dependent enhancement of lignin accumulation, Mol Plant Microbe Interact 28(4) (2015), 398–407.

15.

Bhatia

S.P.

et al., Fragrance material review on sclareol, Food Chem Toxicol 46(Suppl 11) (2008), S270-S274.

16.

Zhang

X.J.

et al., Strophalloside induces apoptosis of SGC-7901 cells through the mitochondrion-dependent caspase-3 pathway, Molecules 20(4) (2015), 5714–5728.

17.

Wang

et al., Mitochondrion-mediated apoptosis is involved in reproductive damage caused by BPA in male rats, Environ Toxicol Pharmacol 38(3) (2014), 1025–1033.

18.